Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
5.10
0.12 (2.41%)
At close: Aug 18, 2025, 3:59 PM
5.10
0.00%
After-hours: Aug 18, 2025, 04:10 PM EDT

Foghorn Therapeutics Revenue

Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending June 30, 2025, Foghorn Therapeutics generated $7.56M in revenue.
Revenue (ttm)
22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
201.8K
Employees
112
Market Cap
288.3M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 22.6M -33.83%
Dec 31, 2023 34.16M +77.63%
Dec 31, 2022 19.23M +1357.77%
Dec 31, 2021 1.32M +206.74%
Dec 31, 2020 430K +Infinity%
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.